Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
- Status
- UNKNOWN
- Phase
- NA
Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- NA
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk
- Status
- RECRUITING
- Phase
- PHASE2